BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

PBPHvsPPHETF Comparison

ETF 1

PBPH

Portfolio Building Block World Pharma and Biotech Index ETF

This fund is part of

DM Large & Mid Cap

+0.48%

Full PBPH fund page

VS

ETF 2

PPH

VanEck Pharmaceutical ETF

This fund is part of

Uncategorized Equities

-0%

Full PPH fund page

Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) belongs to the DM Large & Mid Cap segment. VanEck Pharmaceutical ETF (PPH) is part of the Uncategorized Equities segment. Both ETFs have the same top 1 sector exposures: Healthcare. PBPH is less expensive with a Total Expense Ratio (TER) of 0.13%, versus 0.36% for PPH. PBPH is up 10.08% year-to-date (YTD) with +$968M in YTD flows. PPH performs worse with 7.62% YTD performance, and -$331M in YTD flows. Run a side-by-side ETF comparison of PBPH and PPH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

PBPH vs PPH performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 09/11/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	PBPH PPH	-0.72%-2.26%	+7.13%+2.67%	+10.08%+7.62%	n/a+24.03%	n/a+41.75%	n/a+62.98%
Flows	PBPH PPH	+$35M+$47M	+$139M+$40M	+$968M-$331M	-+$248M	-+$345M	-+$430M

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	PBPH PPH	+20.50%+21.71%	n/a+18.77%	n/a+16.21%	n/a+15.63%
Max drawdown	PBPH PPH	-6.59%-7.13%	n/a-10.78%	n/a-17.98%	n/a-20.19%
Max drawdown duration	PBPH PPH	17d17d	n/a122d	n/a434d	n/a484d

Trading data

Create an account to view trading data

Join for free

	PBPH	PPH
Last sale 9/14/2026 at 1:30 PM	$28.21	$111.14
Previous close 09/11/2026	$27.80	$109.44
Consolidated volume 09/11/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Replication quality

Data as of August 31, 2026

1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free

	PBPH	PPH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst

Main metrics

Last update 9/14/2026 at 1:30 PM

Live

Closed

	PBPH	PPH
Last price	$28.21	$111.14
1D performance	+1.48%	+1.55%
AuM	$1.01 B	$994.73 M
E/R	0.13%	0.36%

Characteristics

	PBPH	PPH
Management strategy	Passive	Passive
Provider	Tidal	VanEck
Benchmark	BITA Global Pharma and Biotech Select Index	MVIS US Listed Pharmaceutical 25 Index
N° of holdings	52	25
Asset class	-	Equities
Trailing 12m distribution yield	Join	Join
Inception date	November 24, 2025	December 20, 2011
ESG	No	No

More PBPH data on Trackinsight

More PPH data on Trackinsight

Exposure

Countries

PBPH

USA

65.24%

Switzerland

10.52%

United Kingdom

7.15%

Other

17.09%

PPH

USA

60.93%

United Kingdom

11.44%

Switzerland

10.54%

Other

17.1%

Sectors

PBPH

Healthcare

99.46%

Other

0.54%

PPH

Healthcare

100%

Other

0%

Diversification

PBPH

Total weight of top 15 holdings out of 15

75.4%

PPH

Total weight of top 15 holdings out of 15

90.28%

Top 15 holdings

Data as of July 31, 2026

PBPH

Eli Lilly & Co.

15.14%

Johnson & Johnson

9.55%

AbbVie, Inc.

7.06%

Merck & Co., Inc.

4.97%

Roche Holding AG

4.70%

Amgen, Inc.

4.62%

Novartis AG

4.45%

AstraZeneca PLC

3.88%

Gilead Sciences, Inc.

3.77%

Novo Nordisk A/S

3.75%

Pfizer Inc.

3.28%

Bristol Myers Squibb Co.

3.06%

Vertex Pharmaceuticals, Inc.

2.82%

GSK Plc

2.24%

Sanofi

2.10%

PPH

Eli Lilly & Co.

19.11%

Novartis AG

10.54%

Merck & Co., Inc.

9.76%

Novo Nordisk A/S

5.67%

Bristol Myers Squibb Co.

4.94%

McKesson Corp.

4.64%

AbbVie, Inc.

4.59%

Pfizer Inc.

4.58%

Johnson & Johnson

4.31%

GSK Plc

4.31%

Sanofi

3.95%

AstraZeneca PLC

3.84%

Cencora, Inc.

3.63%

Haleon Plc

3.29%

Teva Pharmaceutical Industries Ltd.

3.14%

Frequently asked questions about PBPH and PPH

How have the PBPH and PPH ETFs performed in 2026?

As of September 11, 2026, PBPH is up 10.08% year-to-date (YTD), while PPH has returned 7.62%. That puts PBPH better performer ahead so far this year.

Which ETF is attracting more investor money: PBPH or PPH?

Year-to-date, the PBPH ETF saw +$968M in flows, compared to -$331M for PPH.

Which ETF is bigger: PBPH or PPH?

As of September 11, 2026, PBPH holds $1.01 B in assets under management (AUM), while PPH manages $994.73 M.

What sectors do the PBPH and PPH ETFs invest in?

PBPH leans toward sectors like Healthcare. Meanwhile, PPH focuses on Healthcare.

What are the top holdings of the PBPH ETF and PPH ETF?

PBPH top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. PPH holds in its top three: Eli Lilly & Co., Novartis AG and Merck & Co., Inc..

PBPHvsPPHETF Comparison

Portfolio Building Block World Pharma and Biotech Index ETF

VanEck Pharmaceutical ETF

PBPH vs PPH performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the PBPH and PPH ETFs performed in 2026?

As of September 11, 2026, PBPH is up 10.08% year-to-date (YTD), while PPH has returned 7.62%. That puts PBPH better performer ahead so far this year.

Which ETF is attracting more investor money: PBPH or PPH?

Year-to-date, the PBPH ETF saw +$968M in flows, compared to -$331M for PPH.

Which ETF is bigger: PBPH or PPH?

As of September 11, 2026, PBPH holds $1.01 B in assets under management (AUM), while PPH manages $994.73 M.

What sectors do the PBPH and PPH ETFs invest in?

PBPH leans toward sectors like Healthcare. Meanwhile, PPH focuses on Healthcare.

What are the top holdings of the PBPH ETF and PPH ETF?

PBPH top holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc.. PPH holds in its top three: Eli Lilly & Co., Novartis AG and Merck & Co., Inc..

Which ETF is more diversified: PBPH or PPH?

PBPH holds 53 securities with 75.4% of its assets in the top 15. PPH has 25 securities and a top 15 weight of 90.28%.

Healthcare Stocks Rebound

Investing in the Aging Population: A Look at Bonds and Pharma ETFs

Trending sub-sectors in 2022

Build and Analyze Your ETF Portfolio Like a Pro